Medical students' exposure to pharmaceutical industry marketing: A survey at one US medical school
Medical students' exposure to pharmaceutical industry marketing: A survey at one US medical school
复制标题
DOI：
10.1097/00001888-200411000-00005
复制
发表时间：
2004-11-01
影响因子：
7.4
通讯作者：
Pierach, C
中科院分区：
文献类型：
--
作者：
Bellin, M;McCarthy, S;Pierach, C
目的。尽管人们对制药行业和医生之间的互动了解甚多，但对针对医学生的药品营销却知之甚少。本研究旨在描述医学生接触制药行业营销的程度和形式。方法。 2001-02 年，向明尼苏达大学双城分校医学院的 165 名临床前学生和 116 名临床学生发放了一份包含 17 项的匿名调查问卷。主要结果指标是医学生报告的制药行业营销接触的数量和形式，以及学生是否与老师或顾问讨论过这些接触。使用 chi(2) 分析对临床前和临床学生进行比较 (p < .05)。结果。 114 名（69.1%）临床前学生和 107 名（92.2%）临床学生做出了回应。几乎所有学生都至少接触过一次制药行业营销。 76 名临床学生 (71.7%) 与 38 名临床前学生 (33.3%) 相比，回忆起超过 20 次暴露 (P < .005)。与临床前同事相比，临床学生更有可能获得免费餐点 (p < .01)、教科书 (P < .005)、袖珍文本 (P < .005) 或小饰品 (P < .005)。大多数学生（68.2%）没有与讲师或顾问讨论过药品营销； 59 名 (55.7%) 临床学生与 87 名 (80.6%) 临床前学生相比，没有回忆起此类讨论 (P < .005)。结论。医学生在早期培训期间广泛接触了制药行业营销。鉴于现有证据表明此类接触会影响医生的执业和处方模式，作者建议医学院课程应包括正式指导，以帮助学生做好批判性评估这些接触的准备。
Purpose. While much is known about the interactions between the pharmaceutical industry and physicians, very little is known about pharmaceutical marketing directed toward medical students. This study sought to characterize the extent and forms of medical students' exposure to pharmaceutical industry marketing.Method. In 2001-02, an anonymous, 17-item questionnaire was distributed to 165 preclinical and 116 clinical students at the University of Minnesota Medical School-Twin Cities. The main outcome measures were the number and forms of exposures to pharmaceutical industry marketing reported by medical students and whether students had discussed these exposures with teachers or advisors. Preclinical and clinical students were compared using chi(2) analysis (p < .05).Results. One hundred fourteen (69.1%) preclinical students and 107 (92.2%) clinical students responded. Nearly all students reported at least one exposure to pharmaceutical industry marketing. Seventy-six (71.7%) clinical students compared to 38 (33.3%) preclinical students recalled over 20 exposures (P < .005). Clinical students were more likely to have received a free meal (p < .01), textbook (P < .005), pocket text (P < .005), or trinket (P < .005) than were their preclinical colleagues. Most students (68.2%) had not discussed pharmaceutical marketing with an instructor or advisor; 59 (55.7%) clinical students as compared to 87 (80.6%) preclinical students recalled no such discussion (P < .005).Conclusion. Medical students have extensive exposure to pharmaceutical industry marketing during their early years of training. Given existing evidence that such exposure influences physicians' practice and prescribing patterns, the authors propose that medical school curricula include formal instruction to prepare students to critically assess these contacts.